Inactive Instrument

Sector ratings Galapagos NV Euronext Bruxelles

Stocks

End-of-day quote Euronext Bruxelles
-	-

08-25	Lakefront Biotherapeutics, Gilead Secure Another Orphan Drug Designation for Skin Disorder Drug in US	MT
08-24	Lakefront Gets FDA Orphan Drug Label for Gamgertamig	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
GALAPAGOS NV	1.8B	-	B	-	-
LONZA GROUP AG	46.38B		AAA
REVOLUTION MEDICINES, INC.	44.51B	-	B	-	-
IQVIA HOLDINGS INC.	42.3B		AAA
BEONE MEDICINES AG	39.91B		-
CELLTRION, INC.	32.79B		A
ASCENDIS PHARMA A/S	17.13B	-	-	-	-
MEDPACE HOLDINGS, INC.	16.36B		BBB
EUROFINS SCIENTIFIC SE	14.31B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	13.29B		AA
ICON PUBLIC LIMITED COMPANY	12.31B		AAA
TEMPUS AI, INC.	11.06B		A		-
BIO-TECHNE CORPORATION	11.33B		AA
PHARMARON BEIJING CO., LTD.	10.49B		AA
ABIVAX	10.25B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	9.64B	-	B	-	-
KYMERA THERAPEUTICS, INC.	9.6B	-	BBB	-	-
GENSCRIPT BIOTECH CORPORATION	9.39B		AA		-
PROTAGONIST THERAPEUTICS, INC.	9.39B		BB		-
IONIS PHARMACEUTICALS, INC.	9.31B	-	A	-	-
Average	19.46B		A
Weighted average by Cap.			A

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!